Advertisement
Screener

Arbutus Biopharma Corp (ABUS) Material Contracts, 2018

Arbutus Biopharma Corp Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2018-11-07: Form 10-Q; Exhibit 10.1; Description Executive Employment Agreement, dated October 8, 2018, by and between Arbutus Biopharma, Inc. and Gaston Picchio.
  • 2018-05-04: Form 10-Q; Exhibit 10.1; Description EXHIBIT 10.1 GENEVANT MA.
  • 2018-03-16: Form 10-K; Exhibit 10.77; Description Indemnity Agreement between Arbutus Biophrama Corporation and Koert VandenEnden, dated February 16, 2018..
  • 2018-03-16: Form 10-K; Exhibit 10.76; Description Executive Employment Agreement Transfer between Arbutus Biopharma Corporation and Koert VandenEnden., dated February 16, 2018..
FiledFormExhibitDescription
2018-11-0710-Q10.1Executive Employment Agreement, dated October 8, 2018, by and between Arbutus Biopharma, Inc. and Gaston Picchio
2018-05-0410-Q10.1EXHIBIT 10.1 GENEVANT MA
2018-03-1610-K10.77Indemnity Agreement between Arbutus Biophrama Corporation and Koert VandenEnden, dated February 16, 2018.
2018-03-1610-K10.76Executive Employment Agreement Transfer between Arbutus Biopharma Corporation and Koert VandenEnden., dated February 16, 2018.
2018-03-1610-K10.75Termination and Severance Agreement between Arbutus Biopharma Corporation and Bruce Cousins, dated February 8, 2018.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Apnimed, Inc. (APMD)United States$0.899B
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Savara Inc (SVRA)United States$1.044B-9.10
Theravance Biopharma, Inc. (TBPH)$0.885B16.40